W.‐D. Bussmann

The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions

Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

EFFECT OF INTRAVENOUS NITRATES ON MORTALITY IN ACUTE MYOCARDIAL INFARCTION: AN OVERVIEW OF THE RANDOMISED TRIALS

Bone marrow cells regenerate infarcted myocardium

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Results of transvenous buttoned device occlusion of patent ductus arteriosus in adults

Noninvasive Ventilation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Myocardial ischemia-reperfusion injury: a neglected therapeutic target

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Nitroglycerin in the Treatment of Cocaine Associated Chest Pain — Clinical Safety and Efficacy

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure

Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention

Hypertrophic cardiomyopathy

Contrast‐enhanced first pass myocardial perfusion imaging: Correlation between myocardial blood flow in dogs at rest and during hyperemia

EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART)

Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning

Balloon aortic valvuloplasty: Results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry

A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure

Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty Acids

Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy

Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease

Transfemoral closure of patent ductus arteriosus in adult patients

Hypertrophic Cardiomyopathy

Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

A double-blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophic cardiomyopathy

Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope

Antithrombotic Therapy During Percutaneous Coronary Intervention

Conflict of Interest in the Debate over Calcium-Channel Antagonists

Prognosis of patients with unstable angina or acute myocardial infarction treated with calcium channel antagonists

Biomarkers in Heart Failure

Bias in meta-analysis detected by a simple, graphical test

High-dose nitrates in the immediate management of unstable angina: Optimal dosage, route of administration, and therapeutic goals

Treatment of Severe Cardiogenic Pulmonary Edema with Continuous Positive Airway Pressure Delivered by Face Mask

Hypertrophic Cardiomyopathy

Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: Altered left ventricular loading or improved muscle inactivation?

Superior Cardiovascular Effect of Aerobic Interval Training Versus Moderate Continuous Training in Heart Failure Patients

Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function.

Role of electrophysiologic testing in the diagnosis and treatment of patients with known and suspected bradycardias and tachycardias

The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review

Nature of Enhanced Performance of the Dilated Left Ventricle in the Dog during Chronic Volume Overloading

Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators.

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.

Guidelines for the early management of patients with acute myocardial infarction

Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features

Nitrate effects on cardiac output and left ventricular outflow resistance in chronic congestive heart failure

Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans

The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration

Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure

Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary

Mobilized bone marrow cells repair the infarcted heart, improving function and survival

The stunned myocardium: prolonged, postischemic ventricular dysfunction.

Long-term Clinical and Echocardiographic Follow-up After Surgical Correction of Hypertrophic Obstructive Cardiomyopathy With Extended Myectomy and Reconstruction of the Subvalvular Mitral Apparatus

Measurement of Fractional Flow Reserve to Assess the Functional Severity of Coronary-Artery Stenoses

Application of digital techniques to selective coronary arteriography: Use of myocardial contrast appearance time to measure coronary flow reserve

Efforts to Limit the Size of Myocardial Infarcts

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Vasodilator Therapy of Cardiac Failure

Chronic verapamil therapy in pediatrie and young adult patients with hypertrophic cardiomyopathy

Relationship of MRI Delayed Contrast Enhancement to Irreversible Injury, Infarct Age, and Contractile Function

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

Modification of Myocardial Infarction Size After Coronary Occlusion

Blood pressure, stroke, and coronary heart disease

Validation in dogs of a rapid digital angiographic technique to measure relative coronary blood flow during routine cardiac catheterization

Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure

Mechanisms of Diabetic Complications

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Coronary Plaque Disruption

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy.

Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.

Fractional Flow Reserve

Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe.

Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults

Regional left ventricular asynchrony and impaired global left ventricular filling in hypertrophic cardiomyopathy: Effect of verapamil

TIMI Frame Count

Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part II: Hemodynamic Effects and Clinical Applications

Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.

Part 14: Pediatric Advanced Life Support

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina11This document was approved by the American College of Cardiology Board of Trustees in March 1999, the American Heart Association Science Advisory and Coordinating Committee in March 1999, and the American College of Physicians-American Society of Internal Medicine Board of Regents in February 1999.When citing this document, please use the following citation format: Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O’Rourke RA, Schafer WP, Williams SV. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999;33:2092–197.This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org) and the American Heart Association (www.americanheart.org). Reprints of this document are available by calling 1-800-253-4636 or writing the American College of Cardiology, Educational Services, at 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint number 71-0166. To obtain a reprint of the Executive Summary and Recommendations published in the June 1, 1999 issue of Circulation, ask for reprint number 71-0167. To purchase bulk reprints (specify version and reprint number): Up to 999 copies call 1-800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.

Improvement of left ventricular contractile function by exercise training in patients with coronary artery disease.

Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.

Management of Symptoms in Hypertrophic Cardiomyopathy

Nifedipine

A Prospective Evaluation and Follow-up of Patients with Syncope

[Trans-femoral ductus Botalli occlusion in patients over 60 years of age].

Angiotensin-Converting-Enzym-Hemmer bei Angina pectoris

Angiotensin-Konversionsenzym-Hemmer zur Behandlung der Angina pectoris

Double‐blind randomized multicenter study on the efficacy of trapidil versus isosorbide dinitrate in stable angina pectoris

Non-thoracotomy closure of persistent ductus arteriosus beyond age 60 years

Orally administered prajmalium bitartrate in acute and chronic ventricular arrhythmias

Loss of effectiveness of dihydralazine in the long-term treatment of chronic heart failure

Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerin.

Long-Term Treatment of Severe Chronic Heart Failure with Captopril

Effect of sublingual nitroglycerin in emergency treatment of severe pulmonary edema

BLOOD FLOW MEASUREMENT THROUGH SINGLE CORONARY ARTERIES BY ROENTGEN DENSITOMETRY

Orally administered isosorbide dinitrate in patients with and without left ventricular failure due to acute myocardial infarction

Influence of nitroglycerin on the size of experimental myocardial infarction

The Frankfurt experience in restenosis after coronary angioplasty

Nitroglycerin in acute myocardial infarction X. Effect of small and large doses of nitroglycerin on sigma ST segment deviation — Experimental and clinical results

Contractility of the Hypertrophied Canine Heart in Chronic Volume Overload

Treatment of hypertrophic obstructive cardiomyopathy with verapamil.

Reduction of creatine kinase and creatine kinase-MB indexes of infarct size by intravenous verapamil

Perkutane Pulmonalklappensprengung

Blood flow measurement through single coronary arteries by roentgen densitometry. I. A comparison of flow measured by a radiologic technique applicable in the intact organism and by electromagnetic flowmeter.

Ventricular function at rest, during leg raising and physical exercise before and after aortocoronary bypass surgery